Literature DB >> 16616982

Cytokines and serotonin transporter in patients with major depression.

Chiung-Wen Tsao1, Yee-Shin Lin, Chwen-Cheng Chen, Chyi-Huey Bai, Shin-Rung Wu.   

Abstract

Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n=20) and the healthy controls (n=22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n=8). The results revealed that the mRNA expressions of IL-1beta, IL-6, IFNgamma, TNFalpha, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFNgamma and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616982     DOI: 10.1016/j.pnpbp.2006.01.029

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  57 in total

1.  Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms.

Authors:  C M R Franco; A M J Lima; L Ataíde; O G Lins; C M M Castro; A A Bezerra; M F de Oliveira; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2012-03-09       Impact factor: 3.444

2.  Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Lucian Del Fabbro; André Tiago Rossito Goes; Franciele Donato; Silvana Peterini Boeira
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

3.  Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Cristini Escobar Viana; Etiara Mattos; Neici Cáceres Silva; Silvana Peterini Boeira
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

4.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

Review 5.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

6.  Gene expression in major depressive disorder.

Authors:  R Jansen; B W J H Penninx; V Madar; K Xia; Y Milaneschi; J J Hottenga; A R Hammerschlag; A Beekman; N van der Wee; J H Smit; A I Brooks; J Tischfield; D Posthuma; R Schoevers; G van Grootheest; G Willemsen; E J de Geus; D I Boomsma; F A Wright; F Zou; W Sun; P F Sullivan
Journal:  Mol Psychiatry       Date:  2015-05-26       Impact factor: 15.992

7.  Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.

Authors:  H A Eyre; H Lavretsky; J Kartika; A Qassim; B T Baune
Journal:  Pharmacopsychiatry       Date:  2016-03-07       Impact factor: 5.788

8.  Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities.

Authors:  Jonathan Savitz; Mark Barton Frank; Teresa Victor; Melissa Bebak; Julie H Marino; Patrick S F Bellgowan; Brett A McKinney; Jerzy Bodurka; T Kent Teague; Wayne C Drevets
Journal:  Brain Behav Immun       Date:  2012-10-12       Impact factor: 7.217

Review 9.  Gene expression studies in major depression.

Authors:  Divya Mehta; Andreas Menke; Elisabeth B Binder
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

10.  Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions.

Authors:  Carolyn A Fredericks; Emily M Drabant; Michael D Edge; Jean M Tillie; Joachim Hallmayer; Wiveka Ramel; Janice R Kuo; Sean Mackey; James J Gross; Firdaus S Dhabhar
Journal:  Brain Behav Immun       Date:  2009-10-31       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.